NOVEL 2,910 nm ULTRACLEAR® LASER FROM ACCLARO MEDICAL HITS NEW HEIGHTS AT ASLMS 2024, THE PREMIER GLOBAL CONFERENCE ON ENERGY-BASED MEDICINE AND SCIENCE
SMITHFIELD, R.I., April 9, 2024 /PRNewswire/ -- Acclaro Medical proudly announces new clinical study results on nasal contouring, acne scarring, facial resurfacing, facial and neck rejuvenation with stem cell extract and UltraClear® Laser-Coring™ will be presented at the American Society for Laser Medicine and Surgery (ASLMS) global conference, to be held April 11-14, 2024 in Baltimore, MD. UltraClear Laser is acclaimed by aesthetic laser specialists as a game-changer in combating the signs of aging and the effects of gravity with its unrivaled cosmetic results accompanied by patient comfort, rapid healing and superb safety across all skin tones, including skin of color and tanned skin.
- UltraClear Laser is acclaimed by aesthetic laser specialists as a game-changer in combating the signs of aging and the effects of gravity with its unrivaled cosmetic results accompanied by patient comfort, rapid healing and superb safety across all skin tones, including skin of color and tanned skin.
- "We are thrilled that UltraClear laser is taking center stage with its latest clinical study data, outstanding outcomes and innovative Laser-Coring™ techniques at this year's ASLMS meeting," said Shlomo Assa, MSc, Acclaro Medical's President and Chief Technology Officer.
- "Our strong presence exemplifies the bold trajectory and compelling value that UltraClear brings to the future of aesthetic laser skin solutions."
- In addition to the scientific presentations, the company will also sponsor educational events focused on these and other UltraClear laser applications.